Evidence for a secondary state of the human β3-adrenoceptor

被引:25
作者
Baker, JG [1 ]
机构
[1] Univ Nottingham, Queens Med Ctr, Inst Cell Signaling, Nottingham NG7 2UH, England
关键词
D O I
10.1124/mol.105.015461
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
There are three members of the beta-adrenoceptor family, all of which are primarily coupled to G(S) proteins. Recent studies using the huge range of beta-ligands now available have given remarkable new insights into their pharmacology. beta 1-adrenoceptors exist in at least two active conformations, whereas beta 2-adrenoceptors are able to induce signaling via different agonist-induced receptor conformational states, and their affinity for antagonists can be altered by highly efficacious agonists. This study therefore examined the pharmacology of the human beta 3-adrenoceptor stably expressed in Chinese hamster ovary cells. Several compounds described previously as beta-antagonists have agonist properties at the beta 3-adrenoceptor. Antagonist affinity measurements varied at the beta 3-adrenoceptor in a manner similar to those observed at human beta 1-adrenoceptors and unlike those seen at beta 2-adrenoceptors. Some ligands ( e. g., fenoterol and cimaterol) were more readily inhibited by all antagonists, whereas other ligands [ e. g., alprenolol and 1-(2-ethylphenoxy)-3-[[(1S)-1,2,3,4-tetrahydro-1-naphthalenyl] amino](2S)-2-propanol hydrochloride [SR59230A]) stimulated responses that were more resistant to antagonism. Alprenolol inhibited fenoterol-induced beta 3-adrenoceptor responses while acting as an agonist at higher concentrations. This is highly suggestive of two active conformational states of the beta 3-adrenoceptor. (S)-4-[2-Hydroxy-3-phenoxypropylaminoethoxy]-N-(2-methoxyethyl)phenoxyacetamide (ZD7114) stimulated a two-component response, of which the first component was more readily antagonized than the second. Taken together, these experiments suggest that the human beta 3-adrenoceptor exists in at least two different agonist conformations with a similar high- and low-affinity pharmacology analogous to, if not as pronounced as, the beta 1-adrenoceptor. Both conformations are present in living cells and can be distinguished by their pharmacological characteristics. In this respect, the human beta 3-adrenoceptor seems similar to the human beta 1-adrenoceptor.
引用
收藏
页码:1645 / 1655
页数:11
相关论文
共 37 条
[31]   Comparison of the affinity of β-blockers for two states of the β1-adrenoceptor in ferret ventricular myocardium [J].
Lowe, MD ;
Lynham, JA ;
Grace, AA ;
Kaumann, AJ .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (02) :451-461
[32]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[33]   The 'state' of β-adrenoceptors [J].
Molenaar, P .
BRITISH JOURNAL OF PHARMACOLOGY, 2003, 140 (01) :1-2
[34]  
Moniotte S, 2002, CARDIOVASC DRUG REV, V20, P19
[35]   Upregulation of β2-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium [J].
Moniotte, S ;
Kobzik, L ;
Feron, O ;
Trochu, JN ;
Gauthier, C ;
Balligand, JL .
CIRCULATION, 2001, 103 (12) :1649-1655
[36]   Anomalous behavior of CGP 12177A on beta(1)-adrenergic receptors [J].
Pak, MD ;
Fishman, PH .
JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH, 1996, 16 (1-2) :1-23
[37]   Structure and function of the beta(3)-adrenergic receptor [J].
Strosberg, AD .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1997, 37 :421-450